Bank of America
DRNA

Bank of America’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bank of America’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$11K – 7982
2020
Q4 		$11K Buy
+500
New +$11K ﹤0.01% 6707

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

Bank of America's DRNA Position: Q4 2021 in Review

Bank of America sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 135,297 shares — an estimated $2.73M sold.

Bank of America first reported a position in DRNA in Q1 2014 and held it in 31 quarters. The position peaked at $9.27M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • Bank of America reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 135,297 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.73M.
  • Bank of America first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 31 quarters.
  • Bank of America's Dicerna Pharmaceuticals, Inc. position peaked at $9.27M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.